entertainment -WSS

entertainment

author：leisure time 2025-09-30 12:08:42 - browse：7

Two $1 bills stapled together to make the shape of a heart against a red background. -- health policy coverage from STAT — Adobe

WASHINGTON — Doctors lowered the incidence of heart disease and strokes among their patients when Medicare rewarded them for focusing on sicker patients, according to research of a pilot program released Tuesday in the Journal of the American Medical Association. The pilot program didn’t increase overall costs at all.

The five-year pilot program is one of many that Medicare has run since the Affordable Care Act created an office to test whether Medicare payment policies can influence doctors in ways that keep patients healthier. That Obama-era initiative has not worked out as well as was hoped, but the Million Hearts Cardiovascular Disease Risk Reduction Model is one of the initiative’s bright spots.

Medicare paid doctors in the pilot program to assess the risk of heart problems, then Medicare paid them to focus on sicker patients. The pilot paid doctors more when they improved such measurements as blood pressure and cholesterol levels for sicker patients.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： South Korea throws huge K

leisure time

WSS

Naloxone nonprofit donates 200,000 doses after FDA approval

In same hospitals, Black patients receive fewer opioids than white patients

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Why failed clinical trials don’t always spell doom for a new drug

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

NIH trials fail to test meaningful long Covid therapies, experts say

focus

entertainment

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

Emergent cuts jobs, executive role in business shake

Heart attack and stroke risk calculators need revising

Stanford president’s abrupt resignation sparks debate

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wegovy trial has doctors encouraged over new possibilities

At least 13 dead in Texas as scorching temps continue

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

FDA approval of Sarepta Duchenne genetic therapy gives me hope

A new ‘biological computer' targets cancer while sparing healthy cells

Wikipedia

South Korea throws huge K

Judge denies Trump's request for new trial in E. Jean Carroll case

Emergent cuts jobs, executive role in business shake

NIH trials fail to test meaningful long Covid therapies, experts say

Why failed clinical trials don’t always spell doom for a new drug

FDA panel issues narrow recommendation for Covid vaccine booster doses

leisure time

explore

focus

focus